Patent · US Active

Compositions and methods for inhibiting antiapoptotic Bcl-2 proteins as anti-aging agents

US11331328B2 · kind B2 · utility

1Cited by
23References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2015
Grant dateMay 17, 2022
Priority date
Expiry dateMay 5, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K1/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides compositions and methods for selectively killing senescent cells, wherein the selective killing of senescent cells delays aging and treats age-related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.